News Agency
Men's Weekly

US Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

  • Written by PR Newswire

SHANGHAI and JERSEY CITY, N.J., Sept. 2, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) has approved BILDYOS® (denosumab-nxxp) injection 60 mg/mL and BILPREVDA® (denosumab-nxxp) injection 120 mg/1.7 mL, biosimilars to...

Read more: US Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp)...

How Downsizing to a Caravan Can Transform Your Lifestyle

If you’re curious about simplifying life while keeping the sense of adventure, caravan and camping sales offer an inviting gateway. Downsizing to a caravan can transform your daily routine from wrangling a cluttered house every morning to a more manageable... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion